Agenda for Policy Institute on Tuesday, June 11

10:00 a.m. - 10:15 a.m.

Welcome and Introductory Remarks

Paul Gionfriddo, CEO, Mental Health America

10:15 a.m. - 10:45 a.m.

Morning Keynote and the View from Congress

The Honorable Markwayne Mullin, Co-chair of the Congressional Health Care Innovation Caucus and Representative for Oklahoma's 2nd district

10:45 a.m. - 12:00 p.m.

Innovations and Directions in Digital Therapeutics. What are digital therapeutics, what makes them different from other digital health innovations, and what opportunities do they offer to improve mental health and substance use outcomes while reducing consumer costs? We will hear from industry leaders on where they see the field heading, and what it could mean for behavioral health.

Moderated by Megan Coder, PharmD, MBA, Executive Director, Digital Therapeutics Alliance

12:00 p.m. - 12:30 p.m.

Networking Lunch

12:30 p.m. - 1:00 p.m.

Lunch Discussion on Theories of Coverage for Digital Therapeutics. Looking at health care as a whole, what are our options for how digital therapeutics could fit into payment and delivery, and how should we weigh these options as we advocate for policy change? We will hear from a leading health services researcher on the pros-and-cons of different policy approaches for integrating digital therapeutics into the fabric of care.

Adam C. Powell, PhD, President, Payer+Provider Syndicate

1:00 p.m. - 2:00 p.m.

Provider Perspectives on the Clinical Context for Digital Therapeutics. How would providers react to digital therapeutics, and what do they need to effectively use them as part of their care? We will get diverse provider perspectives on what kind of policy changes might better support the health care delivery system to engage with these new technologies.

Ann Greiner, MS, President and CEO, Patient-Centered Primary Care Collaborative

Jeff Micklos, JD, Executive Director, Health Care Transformation Task Force

2:15 p.m. - 3:15 p.m.

Payer Perspectives on the Policy Context for Digital Therapeutics. How do health insurers see digital therapeutics in the flurry of digital innovations, and what kind of policy reforms might help them navigate how and when they want to deploy these technologies? We will get reflections from different insurers and where they see policy challenges and opportunities ahead.

Charles Gross, PhD, Vice President, Behavioral Health, Anthem Inc.

Kate Berry, MPP, Senior Vice President, Clinical Affairs and Strategic Partnerships, America's Health Insurance Plans

3:15 p.m. - 4:30 p.m.

Facilitated Discussion, Next Steps for Policy. Based on what we heard, what can policy-makers and advocates advance on the Hill, with the Administration, or in the states that might help get effective innovations to consumers, and ultimately improve mental health and substance use outcomes while reducing total costs? We will have a group discussion that will help build the foundation for the policy brief.

Moderated by Nathaniel Counts, JD, Associate VP of Policy, Mental Health America

5:00 p.m. - 6:30 p.m.

Networking Reception